Biotech | March 11, 2026
Cirena licenses breakthrough RNA synthesis technology from CU Boulder
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
The conditional, time-limited approval comes through a joint effort with RACTHERA, a joint venture in which Sumitomo Chemical holds a 66.6% stake and Sumitomo Pharma holds 33.4%
ShunzymeX leverages a proprietary protease to streamline purification
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
AA, a chronic immune disease, can cause extensive and unpredictable hair loss
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
Under the deal, ViiV Healthcare will issue new shares to Shionogi for $2.125 billion and cancel Pfizer’s holding
Backed by two CAP - accredited genomics labs in Delhi NCR and Mumbai, supporting oncology, reproductive health, neurology, transplant immunology, and rare diseases
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
